Phase Ib Study of Plx3397, a Csf1R Inhibitor, and Paclitaxel in Patients with Advanced Solid Tumors

Category Primary study
JournalAnnals of Oncology
Year 2014
This article has no abstract
Epistemonikos ID: b13472e52bd4faf1188075f92f66945eab5d98e4
First added on: Feb 19, 2025